Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients.

Noh H, Eomm M, Han A.

J Breast Cancer. 2013 Mar;16(1):55-9. doi: 10.4048/jbc.2013.16.1.55. Epub 2013 Mar 31.

2.

Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.

Bozkurt O, Karaca H, Berk V, Inanc M, Ocak Duran A, Ozaslan E, Ucar M, Ozkan M.

J BUON. 2015 Nov-Dec;20(6):1432-9.

PMID:
26854438
3.

Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.

Hong J, Mao Y, Chen X, Zhu L, He J, Chen W, Li Y, Lin L, Fei X, Shen K.

Tumour Biol. 2016 Mar;37(3):4135-42. doi: 10.1007/s13277-015-4233-1. Epub 2015 Oct 21.

PMID:
26490984
4.
5.
6.

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U, Somali I, Demir L, Bayoglu IV, Yildiz Y, Akyol M, Koyuncu B, Coban E, Ulger E, Unay FC, Tarhan MO.

Int J Clin Oncol. 2015 Feb;20(1):70-81. doi: 10.1007/s10147-014-0672-8. Epub 2014 Feb 18.

PMID:
24532163
7.

High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.

Shao N, Cai Q.

Clin Transl Oncol. 2015 Oct;17(10):772-8. doi: 10.1007/s12094-015-1289-8. Epub 2015 Aug 5.

PMID:
26243392
8.
9.

The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer.

Rimando J, Campbell J, Kim JH, Tang SC, Kim S.

Front Oncol. 2016 Mar 31;6:81. doi: 10.3389/fonc.2016.00081. eCollection 2016.

10.

Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?

Lang BH, Ng CP, Au KB, Wong KP, Wong KK, Wan KY.

World J Surg. 2014 Oct;38(10):2605-12. doi: 10.1007/s00268-014-2630-z.

PMID:
24809487
11.

Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients.

Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T.

Cancer Med. 2014 Apr;3(2):406-15. doi: 10.1002/cam4.204. Epub 2014 Feb 12.

13.

Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.

Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, Dong J, Cheng JW, Liu ZW, Ma L, Lv Y.

Int J Cancer. 2014 May 15;134(10):2403-13. doi: 10.1002/ijc.28536. Epub 2014 Jan 29. Review.

14.

Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK.

Eur Urol. 2014 Dec;66(6):1157-64. doi: 10.1016/j.eururo.2014.02.042. Epub 2014 Feb 26.

PMID:
24630414
15.

Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients.

Azab B, Shah N, Radbel J, Tan P, Bhatt V, Vonfrolio S, Habeshy A, Picon A, Bloom S.

Med Oncol. 2013 Mar;30(1):432. doi: 10.1007/s12032-012-0432-4. Epub 2013 Jan 3.

PMID:
23283648
16.

[Prognostic value of preoperative neutrophil-to-lymphocyte ratio in the elderly patients over 75 years old with gastric cancer].

Zhang X, Li S, Guo Z, Xue Y.

Zhonghua Wei Chang Wai Ke Za Zhi. 2016 May;19(5):526-9. Chinese.

PMID:
27215519
17.

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.

Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, Kim HJ.

BMC Cancer. 2013 Jul 22;13:350. doi: 10.1186/1471-2407-13-350.

18.

Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.

Toh E, Wilson J, Sebag-Montefiore D, Botterill I.

Colorectal Dis. 2014 Mar;16(3):O90-7. doi: 10.1111/codi.12467.

PMID:
24148256
19.

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD.

Ann Surg Oncol. 2012 Jan;19(1):217-24. doi: 10.1245/s10434-011-1814-0. Epub 2011 Jun 3.

PMID:
21638095
20.

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer.

Yao M, Liu Y, Jin H, Liu X, Lv K, Wei H, Du C, Wang S, Wei B, Fu P.

Onco Targets Ther. 2014 Sep 26;7:1743-52. doi: 10.2147/OTT.S69657. eCollection 2014.

Supplemental Content

Support Center